Aurobindo Pharma on March 28, in submission of regulations, announced that they had obtained a particular business and asset from Vererz Healthcare for cash considerations of RS 171 Crore. “Transactions are agreed with consideration of Rs 171 Crore based on debt-free cash. Transactions come into force starting April 1, 2022 and is expected to be […]